Biotique Systems Inc.*
Affymetrix Inc. (AFFX)
Affymetrix licensed the Biotique Local Integration System, a data integration solution
Affymetrix will use the system in its research activities; terms were not disclosed (11/11)
Celsion Corp. (AMEX:CLN)
Asia Pacific Life Sciences Corp. Ltd. (China)
Joint venture to develop and distribute Celsion's products in China
Asia Pacific Life Sciences is a group of Hong Kong-based investors; terms of the deal were not disclosed (12/15)
Epoch Biosciences Inc. (EBIO)
BioControl Systems Inc.*
Nonexclusive license to Epoch's MGB Eclipse technologies
BioControl will use the technology in the area of food testing; Epoch will get access fees, revenues on product sales and royal- ties on resulting end-system sales (10/28)
Locus Pharmaceuticals Inc.*
Collaboration to deploy supercomputing power for research and drug design
Locus will leverage the additional computing power to improve research efficiency; a focus is Locus' program in HIV and AIDS (12/2)
Panacea Pharmaceuticals Inc.*
JSR Corp. (Japan)
To develop and improve assays in Panacea's HAAH oncology program
JSR will provide capabilities in magnetic particle fabrication and surface chemistries; terms were not disclosed (12/9)
Parallel Solutions Inc.*
Phase III Medical Inc. (OTC BB:PHSM)
Royalty agreement for a bioshielding technology with improved delivery of small and large molecules
PSI would pay Phase III a percentage of revenue from the technology in exchange for capital and guidance provided by Phase III (12/12)
# This chart does not include agreements that involve agricultural product development.
* Private companies are indicated with an asterisk.
Unless otherwise noted, the trading symbols listed for public companies are on the Nasdaq market.
AMEX = American Stock Exchange; OTC BB = Over-the-Counter Bulletin Board.